| # | Drug | Count |
|---|---|---|
| 0 | GLATIRAMER ACETATE | 325 |
| 1 | INTERFERON BETA-1A | 240 |
| 2 | ASFOTASE ALFA | 166 |
| 3 | TRIAMCINOLONE ACETONIDE | 165 |
| 4 | INTERFERON BETA-1B | 66 |
| 5 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 37 |
| 6 | MEDROXYPROGESTERONE ACETATE | 30 |
| 7 | GABAPENTIN | 26 |
| 8 | INSULIN GLARGINE | 26 |
| 9 | INSULIN LISPRO | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOMAPACITAN-BECO | 4 | 0.0221 |
| 1 | ASFOTASE ALFA | 166 | 0.0161 |
| 2 | TECHNETIUM TC 99M OXIDRONATE | 1 | 0.0074 |
| 3 | GLATIRAMER ACETATE | 325 | 0.0055 |
| 4 | TRIAMCINOLONE ACETONIDE | 165 | 0.0052 |
| 5 | OCTOCRYLENE, AVOBENZONE | 2 | 0.0045 |
| 6 | SOMATROGON-GHLA | 5 | 0.0040 |
| 7 | INTERFERON BETA-1B | 66 | 0.0035 |
| 8 | LUMASIRAN | 1 | 0.0026 |
| 9 | GLATIRAMER ACETATE INJECTION | 12 | 0.0025 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interferon beta [EPC] | 249 |
| 1 | Corticosteroid [EPC] | 187 |
| 2 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 166 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 51 |
| 4 | Insulin Analog [EPC] | 48 |
| 5 | Provitamin D2 Compound [EPC] | 45 |
| 6 | Benzodiazepine [EPC] | 38 |
| 7 | Vitamin C [EPC] | 29 |
| 8 | Acetylcholine Release Inhibitor [EPC] | 26 |
| 9 | Neuromuscular Blocker [EPC] | 26 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 166 | 0.0161 |
| 1 | Cytolytic Agent [EPC] | 4 | 0.0017 |
| 2 | Provitamin D2 Compound [EPC] | 45 | 0.0015 |
| 3 | Interferon beta [EPC] | 249 | 0.0013 |
| 4 | Recombinant Human Growth Hormone [EPC] | 16 | 0.0007 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 6 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 7 | Human Immunoglobulin G [EPC] | 9 | 0.0004 |
| 8 | Potassium Channel Blocker [EPC] | 19 | 0.0003 |
| 9 | Acetylcholine Release Inhibitor [EPC] | 26 | 0.0003 |